Verified email-pattern data for Laekna is currently limited. You can still use the company insights and contact sections below.
Founded in 2016, Laekna is a science-driven, clinical-stage biotechnology company committed to bringing novel therapeutics to patients with metabolic diseases, cancer and liver fibrosis around the world.
As of December 31, 2024, Laekna has initiated seven clinical trials for LAE102, LAE002(afuresertib), LAE001 and LAE005 to address unmet medical needs in obesity and cancers.
LAE102 is our internally discovered antibody against ActRIIA. Blocking Activin-ActRII pathway could promote muscle regeneration and decrease fat mass, this positions LAE102 as a promising drug candidate for achieving quality weight control. We’ve obtained IND approvals from the FDA and the CDE for LAE102 in obesity indication and are advancing the Phase I clinical trial in China. In November 2024, Laekna entered into a clinical collaboration agreement with Eli Lilly and Company to support and accelerate global clinical development of LAE102.
Laekna team has accumulated tremendous experiences and deep know-how in the specific field of targeting ActRII receptors and is developing more drug candidates (LAE103 and LAE123), in addition to LAE102, to maximize the value of the target. LAE103 is an ActRIIB-selective antibody and LAE123 is a dual inhibitor against ActRIIA/IIB. Both are our internally discovered antibodies for muscle and other disease indications.
In the cancer area, Laekna has built a comprehensive portfolio of drug candidates including LAE002(afuresertib), LAE001 and other seven pre-clinical drug candidates. LAE002 (afuresertib) is one of the only two AKT inhibitors in late-stage development for breast and prostate cancer globally. Laekna has commenced the Phase III clinical trial (AFFIRM-205) for LAE002 in patients with HR+/HER2- breast cancer and the study recruitment is on track.
Laekna, Inc. (2105.HK) was listed on the Main Board of The Stock Exchange of Hong Kong Limited on June 29, 2023.
For more information, please visit: https://www.laekna.com/
Company Details
- Employees
- 30
- Founded
- -
- Address
- 浦东新区张江, 蔡伦路987号5楼,china
- Industry
- Pharmaceutical Manufacturing
- Website
- http://www.laekna.com/
- HQ
- 上海, 上海
Laekna Questions
Laekna's website is http://www.laekna.com/
Laekna's LinkedIn profile is https://cn.linkedin.com/company/laekna
Laekna has
30 employees.
View email and phone details for 30
employees at Laekna.
Laekna's industry is
Pharmaceutical Manufacturing
Laekna's top competitors are
Insilico Medicine,
Innovent Biologics,
Abbvie,
Harbour Biomed,
Nucleate,
Henlius,
Hutchmed,
Fusion Vc,
Odyssey Therapeutics,
Gan & Lee Pharmaceuticals.
Laekna's categories are Pharmaceutical Manufacturing
Laekna's founding year is 2016
Top Laekna Employees
-
Yong Yue
Chief Medical Officer, Laekna…
New York City Metropolitan Area, United States, United States3yahoo.com, laeknatp.com, gsk.com -
Susan Wang
Hiring For Laekna
Dallas-Fort Worth Metroplex, United States, United States4huawei.com, huawei.com, segwaypowersports.us, huawei.com4 +121491XXXXX
-
Justin Gu
Chief Scientific Officer At Laekna…
Shanghai, China, China1novartis.com -
Guy Rosenthal
Biotech, Pharma And Healthcare…
Los Angeles, California, United States, United States2vblrx.com, laeknatp.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.